JPMorgan raised the firm’s price target on Teradyne (TER) to $190 from $122 and keeps a Neutral rating on the shares. The company reported “robust” revenue growth in Q3 with an outlook for further acceleration in Q4, the analyst tells investors in a research note. The firm upped estimates post the print.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TER:
- Teradyne’s Q3 2025 Results Highlight AI-Driven Growth
- Teradyne’s Earnings Call: AI Demand Drives Growth
- Teradyne double upgraded to Buy at BofA on multi-year acceleration
- Teradyne upgraded to Buy from Underperform at BofA
- Teradyne’s Promising Growth Prospects: Buy Rating Backed by Strong AI Compute and Memory Test Demand